The Journal of Toxicological Sciences · 2009 · 33 citations · 21 references
PharmacyPharmacologyToxicologyHepatotoxicologyMolecular PharmacologyMolecular ToxicologyBiomarkers Of Liver InjuryHepatic PathophysiologyHepatic ToxicityHepatotoxicity MechanismsAspartate Aminotransferase ElevationBiomarkers Of Liver ToxicityCoagulationHepatotoxic MechanismsLiver Disease-associated CoagulopathyLiver Toxicity MechanismsSerum Alanine AminotransferaseSerum Aspartate Aminotransferase
A large-scale transcriptome database of rat liver (TG-GATEs) has been established by the Toxicogenomics Project in Japan. In the present study, we focused on 8 hepatotoxic compounds within TG-GATEs, i.e., clofibrate, omeprazole, ethionine, thioacetamide, benzbromarone, propylthiouracil, Wy-14,643 and amiodarone, which induced coagulation abnormalities. Aspirin was selected as a reference compound that directly causes coagulation abnormality, but not through liver toxicity. In blood chemical examinations, for all the coagulopathic compounds there was little elevation of aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT), suggesting no severe cell death by treatment with the compounds. We extracted 344 probe sets from the data for these 8 typical drugs, which induced this phenotype at any time from 3 to 28 days of repeated administration. Principal component analysis using these probe sets clearly separated dose- and time-dependent clusters of the treated groups from their controls, except aspirin and propylthiouracil, both of which were considered to cause coagulopathy not due to their hepatotoxicity but due to their direct effects on the blood coagulation system. Reviewing the extracted genes, changes in lipid metabolism were found to be dominant. Genes related to blood coagulation were generally down-regulated by these drugs except that vitamin K epoxide reductase complex subunit 1 (Vkorc1) like 1, a paralogous gene of Vkorc1, was up-regulated. As expected, expression changes of these genes were least prominent in aspirin or propylthiouracil-treated liver. We concluded that these probe sets could be a good starting point in developing mechanism-based biomarkers for diagnosis or prognosis of hepatotoxicity-related coagulation abnormalities in the early stage of drug development.
21
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Glynn Dennis, Brad T. Sherman, Douglas A Hosack et al. · Genome biology · 2003 · 9.5K citations · Full text
Association of warfarin dose with genes involved in its action and metabolism
Mia Wadelius, Leslie Y. Chen, Niclas Eriksson et al. · Human Genetics · 2006 · 397 citations · Full text
Medicine, Genetics, Pharmacology +13
Brian Savage, Sanford J. Shattil, Zaverio M. Ruggeri · Journal of Biological Chemistry · 1992 · 322 citations · Full text
Medicine, Biochemistry, Cell Biology +17
The Vascular Biology of the Glycoprotein Ib-IX-V Complex
Yang Shen, Sacha M. Dopheide, Elizabeth E. Gardiner et al. · Thrombosis and Haemostasis · 2001 · 278 citations